Tuesday, January 16, 2018

In January 2018 the HIT CF project kicked off.
This European project brings together researchers, doctors, pharmaceutical companies and patient representatives with the aim to develop ‘personalized treatments’ for Cystic Fibrosis (CF) patients throughout Europe and uncommon genetic profiles. The project is funded by the EU under the Horizon 2020 framework.

HIT-CF video Announcement from Ruud Bisseling on Vimeo.

Press release